Submission Details
| 510(k) Number | K233445 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 19, 2023 |
| Decision Date | January 17, 2024 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K233445 is an FDA 510(k) clearance for the Bactiseal Catheters; Bactiseal Barium Striped Catheters; Bactiseal Endoscopic Ventricular Catheter, a Shunt, Central Nervous System And Components (Class II — Special Controls, product code JXG), submitted by Integra Lifesciences Production Corporation (Mansfield, US). The FDA issued a Cleared decision on January 17, 2024, 90 days after receiving the submission on October 19, 2023. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5550.
| 510(k) Number | K233445 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 19, 2023 |
| Decision Date | January 17, 2024 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | JXG — Shunt, Central Nervous System And Components |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5550 |